OGI
Organigram Global Inc
NASDAQ · Pharmaceuticals
$1.53
+0.05 (+3.38%)
Open$1.49
Previous Close$1.48
Day High$1.56
Day Low$1.49
52W High$55.02
52W Low$24.84
Volume—
Avg Volume146.1K
Market Cap274.06M
P/E Ratio20.90
EPS$1.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,492.8% upside
Current
$1.53
$1.53
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 80.01M | 81.33M | 78.64M |
| Net Income | 10.95M | 15.27M | 12.59M |
| Profit Margin | 13.7% | 18.8% | 16.0% |
| EBITDA | 20.99M | 21.57M | 20.37M |
| Free Cash Flow | 12.68M | 16.42M | 10.74M |
| Rev Growth | -6.4% | -3.5% | +20.8% |
| Debt/Equity | 0.21 | 0.20 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |